AIM Vaccine Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-277.23	-1,301	-319.6	-692.77
Depreciation & Amortization	165.46	169.18	163.41	142.24
Other Amortization	6.57	5.52	3.03	2.06
Loss (Gain) From Sale of Assets	0.14	7.15	0.69	0.21
Asset Writedown & Restructuring Costs	32.75	1,785	-	-
Loss (Gain) From Sale of Investments	-0.08	-	-3.07	-1.67
Stock-Based Compensation	-	-14.2	225.76	952.13
Provision & Write-off of Bad Debts	-6.26	4.18	27.22	7.98
Other Operating Activities	43.7	-932.86	-131.15	10.67
Change in Accounts Receivable	-112.43	43.35	-16.16	-201.77
Change in Inventory	20.45	-15.64	-161.99	-136.36
Change in Accounts Payable	-9.46	-13.23	21.82	13.79
Change in Unearned Revenue	-21.65	-0.26	16.12	-28.91
Change in Other Net Operating Assets	257.23	97.56	63.6	25.82
Operating Cash Flow	99.19	-165.5	-110.32	93.4
Operating Cash Flow Growth	-	-	-	-62.69%
Capital Expenditures	-121.75	-158.92	-779.01	-1,125
Sale of Property, Plant & Equipment	0.01	1.66	0.19	0.02
Cash Acquisitions	-	-	-	-250.38
Sale (Purchase) of Intangibles	-115.76	-80.14	-77.33	-0.23
Investment in Securities	51.96	8.12	-56.93	5.9
Other Investing Activities	23.2	-42.69	54.93	32.55
Investing Cash Flow	-162.35	-271.96	-858.15	-1,338
Long-Term Debt Issued	1,089	1,458	1,282	537.83
Long-Term Debt Repaid	-1,054	-1,048	-452.86	-261.04
Net Debt Issued (Repaid)	34.63	410.27	829.16	276.79
Issuance of Common Stock	-	-	162.02	553.48
Other Financing Activities	-60.85	-48.2	-10.8	-42.24
Financing Cash Flow	-26.22	362.07	980.37	788.02
Foreign Exchange Rate Adjustments	0.5	2.27	-2.38	-
Net Cash Flow	-88.88	-73.12	9.53	-456.09
Free Cash Flow	-22.56	-324.42	-889.33	-1,032
Free Cash Flow Margin	-1.75%	-27.32%	-70.35%	-65.73%
Free Cash Flow Per Share	-0.02	-0.27	-0.74	-0.89
Cash Interest Paid	60.85	43.2	24.59	10.3
Cash Income Tax Paid	17.98	0.92	59.57	90.03
Levered Free Cash Flow	14.41	-1,217	-801.43	-514.34
Unlevered Free Cash Flow	52.4	-1,189	-785.37	-507.65
Change in Working Capital	134.14	111.78	-76.6	-327.44

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.